FAQ
    
    AGREEMENT STATES
    
    Facility Locator
    
    What's New
    
    Site Help
    
    Index A-Z
    
    Contact Us
    
    Email Updates
      
      
      
      
       
      Report a Safety Concern
                  Search
        Nuclear Reactors
  
  Power Reactors
Research & Test ReactorsOperating Reactors
New ReactorsOperator Licensing
Research ActivitiesNuclear Reactor Quick LinksNuclear Materials
  
  Types of Nuclear Materials
Fuel Cycle Facilities
Medical, Industrial, & Academic UsesUranium Recovery
Materials TransportationMaterials Environmental Reviews
National Materials ProgramNuclear Materials Quick LinksRadioactive Waste
  
  Decommissioning of Nuclear Facilities
Low-Level Waste
Waste Incidental to Reprocessing
High-Level WasteUranium Mill Tailings
Low-Level Waste Disposal
High-Level Waste DisposalStorage of Spent Nuclear Fuel
Transportation of Spent Nuclear Fuel
Research ActivitiesRadioactive Waste Quick LinksNuclear Security
  
  Domestic Safeguards
Information Security
Radioactive Material SecurityRequired Reporting for Clearance Holders
Insider Threat Program for Licensees
CybersecurityCriminal History & Firearms Checks
Contact UsPublic Meetings & Involvement
  
  The NRC Approach to Open Government
About Meetings Open to the Public
Conferences & SymposiaDocuments for Comment
NRC Rules and Petitions
Facilitating Stakeholder InvolvementNRC Information Quality Guidelines
Subscribe to E-mail UpdatesCommission Schedule
Public Meeting ScheduleAdjudications (Hearings)
Adjudicatory SubmissionsNRC Library
  
  Basic References
Document Collections
ADAMS Public Documents
Public Document Room
LSN LibraryFOIA & Privacy Act
Photos & Videos
Records Management
Training CoursesFAQ Index
Get Copies of Documents
Withholding of Sensitive Information
Controlled Unclassified Information Program (CUI)Electronic Hearing DocketAbout NRC
  
  The Commission
Organization & Functions
Governing Legislation
Plans, Budget, & Performance
Locations
History
Values
Direction-Setting & Policymaking
Research Activities
Radiation ProtectionFire Protection
Safety Culture
How We Regulate
Emergency Preparedness & Response
Public Affairs
Congressional Affairs
Enforcement
International Programs
State & Tribal ProgramsAlternative Dispute Resolution Programs
Privacy Program
Civil Rights Program
Contact Us
Career Opportunities
Contracting Opportunities
Small Businesses
Grant Opportunities
Generic SchedulesOther Links
  
  FAQ
Glossary
Facility Locator
What's NewSite Help
Index A-Z
Contact Us
Email UpdatesNRC Facebook
NRC Twitter Feed
NRC Linkedin
NRC Youtube Channel
NRC Flickr Gallery
NRC Blog Archived
NRC Email Subscriptions - GovDelivery Home
          NRC Library  Document Collections  NUREG-Series Publications  Publications Prepared by NRC StaffSafety Evaluation Report: Northwest Medical Isotopes, LLC Construction Permit Application for a Radioisotope Production Facility (NUREG-2229)

On this page:

Publication Information
	AbstractDownload complete document

NUREG-2229 (PDF – 2.81 MB)Publication Information
**Manuscript Completed:** May 2018**Date Published:** May 2020

Office of Nuclear Regulatory Regulation
U.S. Nuclear Regulatory Commission
Washington, DC 20555-0001

Availability Notice

Abstract
This safety evaluation report (SER) documents the results of the safety review conducted by the U.S. Nuclear Regulatory Commission (NRC) staff (the staff) on the Northwest Medical Isotopes, LLC (NWMI or the applicant) application to obtain a construction permit for a production facility (NWMI production facility or facility) under Title 10 of the *Code of Federal Regulations* (10 CFR) Part 50, "Domestic Licensing of Production and Utilization Facilities," to be constructed in Columbia, Missouri. Subject to 10 CFR Part 50, the proposed production facility would receive irradiated special nuclear material (SNM), and process the SNM to produce the medical radioisotope molybdenum-99. The production facility would be part of a larger facility, which the staff refers to as the radioisotope production facility (RPF), and which would also include target fabrication activities conducted under 10 CFR Part 70, "Domestic Licensing of Special Nuclear Material." Although the staff reviewed NWMI's entire application, including information related to the 10 CFR Part 70 activities, to understand the interfaces between the 10 CFR Part 50 and 10 CFR Part 70 portions of the RPF, the staff findings in this SER are limited to those required for licensing a production facility under 10 CFR Part 50.

This SER presents the results of the staff's review of the NWMI construction permit application as updated on September 8, 2017, and as supplemented by the applicant's responses to requests for additional information (RAIs).

The staff's environmental review of the NWMI construction permit application is documented in NUREG-2209, "Environmental Impact Statement for the Construction Permit for the Northwest Medical Isotopes Radioisotope Production Facility."

The NRC's Advisory Committee on Reactor Safeguards (ACRS) independently reviewed those aspects of the application that concern safety and provided the results of its review to the Commission in a report dated November 6, 2017. Appendix D, "Report by the Advisory Committee on Reactor Safeguards," to this SER includes a copy of the report by the ACRS on the NWMI construction permit application.

Based upon the review documented in the SER, the staff finds that the preliminary design and analysis of the NWMI production facility, including the principal design criteria; design bases; information relative to materials of construction, general arrangement, and approximate dimensions; and preliminary analysis and evaluation of the design and performance of structures, systems, and components (SSCs) of the facility, as described in the NWMI preliminary safety analysis report, as supplemented by responses to RAIs: (1) provides reasonable assurance that the final design will conform to the design basis; (2) includes an adequate margin of safety; (3) demonstrates that SSCs adequately provide for the prevention of accidents and the mitigation of consequences of accidents; and (4) meets applicable regulatory requirements as well as applicable NRC guidance. Therefore, the staff recommends that the Commission make the necessary findings with respect to the safety of the construction permit in accordance with 10 CFR 50.35, "Issuance of construction permits"; 50.40, "Common standards"; and 50.50, "Issuance of licenses and construction permits."

The Commission issued its Memorandum and Order, CLI–18–06, documenting its final decision on the mandatory hearing held on January 23, 2018. The Commission's final decision authorized the issuance of the construction permit for the NWMI medical radioisotope production facility, contingent upon the inclusion of a revised safety permit condition. In May 2018, the staff updated the permit condition in Section 2.4.5 and Appendix A.1 of this SER to reflect the Commission's final decision. The staff also reformatted the permit condition related to the criticality accident alarm system in Section 6.4.5 of this SER for clarity.
      
      Page Last Reviewed/Updated Tuesday, March 09, 2021  Home
NEWS RELEASES

EVENT REPORTS

ADAMS

OPEN GOV

DIGITAL GOVERNMENT

THE STUDENT CORNER

PHOTOS & VIDEOS

FOR DEVELOPERS
        About Us
STRATEGIC PLAN

BUDGET & PERFORMANCE

AGENCY FINANCIAL REPORT

LICENSE FEES

HISTORY OF THE NRC

CAREER OPPORTUNITIES

NRC ETHICS

AGENCY STATUS

CONTACT US
        Popular Documents
INFO DIGEST

FACT SHEETS & BROCHURES

FORMS

ELECTRONIC SUBMITTALS APPLICATION

ADJUDICATORY SUBMISSIONS

NRC REPORTS - NUREG

NRC REGULATIONS - 10-CFR

INSPECTION REPORTS

PLAIN WRITING

ENFORCEMENT ACTIONS

RULEMAKING

GLOSSARY
        Stay Connected
    
    
    
    
    United States Nuclear Regulatory Commission
    
    
    
    
    Regulations.gov

USA.gov

FOIA

Whistleblower Protection

No Fear EEO

Inspector General

Site Map

Accessibility

Privacy Policy

Site Disclaimer

For Employees